MRAIMarpai, Inc.

Nasdaq www.marpaihealth.com


$ 2.29 $ -0.14 (-5.88 %)    

Friday, 10-May-2024 15:34:33 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 2.24
$ 2.47
$ 0.00 x 0
$ 0.00 x 0
$ 2.29 - $ 2.47
$ 0.33 - $ 3.46
159,149
na
21.07M
$ 0.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-29-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 12-14-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 marpai-q1-2024-gaap-eps-046-beats-049-estimate-sales-7385m-miss-8700m-estimate

Marpai (NASDAQ:MRAI) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.49) by 6.1...

 marpai-implements-cost-reduction-program-and-sublease-of-one-of-its-properties

These initiatives are expected to generate $3 million in annual savings and position the Company for continued financial strength.

 maxim-group-upgrades-marpai-to-buy-announces-6-price-target

Maxim Group analyst Allen Klee upgrades Marpai (NASDAQ:MRAI) from Hold to Buy and announces $6 price target.

 marpai-q4-eps-065-up-from-164-yoy-sales-871m-inline

Marpai (NASDAQ:MRAI) reported quarterly losses of $(0.65) per share. This is a 60.37 percent increase over losses of $(1.64) pe...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

 earnings-preview-for-marpai
Earnings Preview For Marpai
03/25/2024 15:00:40

 nasdaq-panel-grants-marpais-request-for-extension-to-comply-with-continued-listing-requirements

Marpai, Inc. ("Marpai" or the "Company") (NASDAQ:MRAI), an independent national Third-Party Administration (TPA...

 why-oracle-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket

Shares of Oracle Corporation (NYSE: ORCL) rose sharply in today’s pre-market trading after the company reported upbeat earning...

 15m-bet-on-this-penny-stock-check-out-these-4-stocks-under-5-insiders-are-aggressively-buying

The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 why-crowdstrike-shares-are-trading-higher-by-around-24-here-are-20-stocks-moving-premarket

Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company rep...

 marpai-expects-to-take-a-30m-non-cash-goodwill-impairment-charge-in-q4

Goodwill Impairment The Company expects to take a $3.0 million non-cash goodwill impairment charge in the fourth quarter ...

 marpai-reports-prelim-q4-net-revenue-of-87m-vs-871m-est-and-fy23-net-revenue-of-372m-vs-3462m-est

Marpai, Inc. ("Marpai" or the "Company") (NASDAQ:MRAI), an independent national Third-Party Administration (TPA...

 marpai-announces-off-cycle-new-client-agreement-financial-terms-not-disclosed

Marpai executes new client agreement furthering its expansion in the Southeast.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION